Jubilant Life Sciences receives credit ratings from India Ratings and Research

Explore Business Standard
Associate Sponsors

1 Fund-based Working Capital limits (Rs 475 crore) - INDAA/RWE/IND A1+/RWE
2 Non-fund-based Working Capital limits (Rs 772.50 crore) - IND A1+/RWE
3 Commercial Paper programme (Rs 400 crore) - Withdrawn (the Company did not proceed with the instrument as envisaged)
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
First Published: Oct 31 2020 | 12:48 PM IST